Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Lynch loses Autonomy fraud caseMike Lynch, the billionaire founder of software maker Autonomy, has lost a fraud case brought by Hewlett Packard Enterprise....
...There was a March release date given for Gran Turismo 7 and the unfortunate slippage of Grand Theft Auto V from November to March. Axios has more....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...DD’s Indap v NYU’s Damodaran: Is stock compensation good or bad?...
...According to Dealogic, since 2010 less than 50 per cent have succeeded, meaning that the odds are against Hock Tan and his long list of deal advisers (Moelis, Citi, Deutsche Bank, JPMorgan, BofA Merrill Lynch...
...Jenny Alltoft, head of global biosimilars at Pfizer, highlighted the cost, in both cash and time, of developing a biosimilar....
...It could spend another $14bn without undertaking a rights issue, calculates Bank of America Merrill Lynch....
...Follow David J Lynch on Twitter: @davidjlynch...
...SpringWorks will be led by executive chairman Dan Lynch, who has held various executive jobs at a string of biotechs, and Lara Sullivan, who is leaving her role at Pfizer to become president of the new group...
...MUFG’s former private banking joint venture with Merrill Lynch was struck by Mr Hirano and James Gorman (now Morgan Stanley’s chief executive) when he headed Merrill’s private client business....
...Smart reads David v Goliath Large consumer goods companies are starting to feel the impact of their smaller, more innovative rivals....
...Thomas Sheehan, head of global healthcare at Bank of America Merrill Lynch, said despite the slowdown the fundamentals for dealmaking remained unchanged and activity was bound to pick up again....
...Last year, for example, Halliburton and Baker Hughes scrapped their $28bn marriage while Pfizer abandoned a $160bn takeover of Allergan....
...Volatility in Treasury markets has surged to its highest level since February, according to Bank of America Merrill Lynch....
...In the Salman case, the Supreme Court reaffirmed its 1983 ruling in Dirks v SEC, which held that when an insider gives trading information to a relative or friend, it is effectively the same as if the insider...
...Trivago, which began as German start-up, said it will issue American depository shares representing class A shares of its affiliate, Travel B.V., which will be listed on the Nasdaq Global Select Market under...
...Christopher Cole was toiling away deep inside Merrill Lynch’s New York office, arranging complicated debt structures for pension funds and insurers, when he fell in love with volatility. ———————————— Volatility...
...But Thomas Sheehan, global head of healthcare at Bank of America Merrill Lynch, said that not all biotech companies were in need of fresh funding....
...“Competitive insurance markets are essential to providing Americans the affordable and high-quality healthcare they deserve,” said Loretta Lynch, the US attorney-general....
...Ms Lynch, his boss, spoke the same day of deals that “were so obviously uncompetitive that they were doomed from the inception”....
...In a speech on Wednesday night, Loretta Lynch, US attorney-general, said the DoJ would “not allow management to increase investor value at the expense of the individual consumer"....
...Pfizer ’s announcement came one day after the US Treasury proposed new rules on “inversion” deals....
International Edition